An analysis of 15,000 insured people with HIV also confirmed past findings that single-tablet regimens are associated with higher adherence.

People who received the vaccine did, however, show stronger immune responses against the virus.

Surveys reveal difficulties associated with daily pills and a desire for long-acting injectable therapy.

Researchers at George Washington University take a look.

Increases in syphilis have been driven by new cases in men who have sex with men, an estimated half of whom have HIV.

Expanded access study confirms the long-acting monoclonal antibody works well in people with extensive prior treatment.

By altering the components of the vaccine regimen, researchers drove promising antibody and immune-cell responses.

A long-term study also found that superinfection—acquiring a second strain of HIV—was not a risk for the transplantees.

The opioid epidemic is principally responsible for a recent increase in infective endocarditis in the United States.